Prosecution Insights
Last updated: November 20, 2026
Application No. 18/006,811

COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS

Non-Final OA §103
Filed
Jan 25, 2023
Priority
Sep 23, 2020 — nonprovisional of PCTCN2020116942
Examiner
OGDEN JR, NECHOLUS
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
L'Oréal
OA Round
5 (Non-Final)
70%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
737 granted / 1056 resolved
+4.8% vs TC avg
Strong +24% interview lift
Without
With
+23.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
48 currently pending
Career history
1109
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
47.6%
+7.6% vs TC avg
§102
19.6%
-20.4% vs TC avg
§112
14.8%
-25.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1056 resolved cases

Office Action

§103
Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 10-15-2026 has been entered. Claim Rejections - 35 USC § 103 Claim(s) 1-9, 11, 13-16 are rejected under 35 U.S.C. 103 as being unpatentable over NADAU-FOURCADE (2016/0206590) in view of WO (2019/127001). NADAU-FOURCADE discloses a composition that is a topical washing emulsion for treating skin, comprising: a) Benzoyl peroxide (BPO) b) At least one mild surfactant with cleaning and / or foaming properties compatible with BPO, selected from classes of anionic and / or non-ionic surfactants c) zinc gluconate d) dipotassium glycyrrhizate e) an oily phase f) at least one nonionic emulsifier from the family of sugar ester derivatives, and / or polyglycerol esters and / or twin surfactants (030-037). NADAU-FOURCADE discloses desirable foaming surfactants such sodium lauroyl glutamate, sodium cocoyl glycinate and alkyl sulfosuccinates, such as sodium dioctyl sulfosuccinate, alkyl ether sulfosuccinates, alkyl amido sulfosuccinates (047-055). NADAU-FOURCADE teach that said foaming surfactants are present from 0.2-20% actives and up to 10% by weight of the composition (063). In addition, it is suggested within the composition that it also comprises zinc gluconate. Zinc gluconate (also called zinc gluconium) is the zinc salt of gluconic acid. It is an ionic compound consisting of two moles of gluconate to one mole of zinc. Zinc gluconate is a popular way of administering zinc as a dietary supplement (066). Moreover, the concentration of zinc gluconate expressed by weight in relation to the total weight of the composition is between 0.1 and 1%, preferably between 0.15 and 0.3, and more preferably, 0.2 % (068). Notably, the composition of the invention is an oil-in-water emulsion, containing an aqueous phase with at least 5% water by weight of the total composition, and preferably between 5 and 90% (048) and also includes polyhydric alcohols such as glycerol or glycerin, the amount of polyol of the invention is between 0.1 and 40% by weight relative to the total weight of the composition (080-081). See claim 1. NADAU-FOURCADE disclose all of the instantly required except the specific disodium lauryl sulfosuccinate surfactant and proportions of at least 20% by weight of said surfactants or 20.5% of total surfactants including anionic and amino based. WO ‘001 disclose a makeup removing composition that comprises mixing water and the composition to deliver to the skin (page 24, lines 9-14) and comprising surfactants such as well-known anionic surfactants such as C6-C24 alkyl sulfosuccinates; C6-C24 acyl glutamates and C6-C24 acyl glycinates and mixtures thereof (page 17, lines 21-32 and page 20, lines 21-24). It would have been obvious to the skill artisan in skin care, cleansing and make up removing to include anionic surfactants such as sulfosuccinates, glycinates and glutamates within the range of 20.5% by weight given the teachings of NADAU-FOURCADE and WO ‘001 where said surfactants are well known in the skin car and personal cleansing art for their foaming properties which is suggested in WO ‘001 and desired for formulation in the NADAU-FOURCADE composition. One skilled in the art, in the absence of a show commensurate in scope with the claimed invention, would have been motivated to include the anionic surfactants as listed within their requisite proportions for the purpose of increasing foaming. [W]hen a patent 'simply arranges old elements with each performing the same function it had been known to perform' and yields no more than one would expect from such an arrangement, the combination is obvious. [KSR Int'l Co. v.Teleflex Inc., 550 U.S. at 418 (quoting Sakraida v. Ag Pro, Inc., 425 U.S. 273,282 (1976).] “The normal desire of scientists or artisans to improve upon what is already generally known provides the motivation to determine where in a disclosed set of percentage ranges is the optimum combination of percentages” Peterson, 315 F.3d at 1330, 65 USPQ2d at 1382; In re Hoeschele, 406 F.2d 1403, 160 USPQ 809 (CCPA 1969) Merck & Co. Inc. v. Biocraft Laboratories Inc., 874 F.2d 804, 10 USPQ2d 1843 (Fed. Cir.), cert. denied, 493 U.S. 975 (1989); In re Kulling, 897 F.2d 1147, 14 USPQ2d 1056 (Fed. Cir. 1990); and In re Geisler, 116 F.3d 1465, 4 3 USPQ2d 1362 (Fed. Cir. 1997). Response to Arguments Applicant's arguments filed 10-15-2026 have been fully considered but they are not persuasive. Applicant argues that NADAU-FOURCADE teach the salt of gluconate from 0.15-0.4%, outside of the amended 0.5-2.5%. The examiner disagrees and directs applicants attention to the para 0068 and 0146 of NADAU-FOURCADE where the range is clearly suggested from 0.1-1.0% by weight of zinc (divalent salt) of gluconic acid and encompasses the broad range as amended. One skilled in the art would clearly envision component (c) of the tertiary composition as claimed given the specific teachings of each of the claimed ingredients utilized for the same purpose, in the absence of a showing to the contrary. Applicant’s rep. points to examples 1-3 and comparative example 3 as criticality over the prior art of record. The examiner contends that applicant’s claims are not commensurate in scope with the broad tertiary composition of the most comprehensive claim yet the examples relied upon require a myriad and plethora of components not suggested by the claims. Therefore, the claims are not commensurate in scope and criticality cannot be established. Whether the unexpected results are the result of unexpectedly improved results or a property not taught by the prior art, the “objective evidence of nonobviousness must be commensurate in scope with the claims which the evidence is offered to support.” In other words, the showing of unexpected results must be reviewed to see if the results occur over the entire claimed range. In re Clemens, 622 F.2d 1029, 1036, 206 USPQ 289, 296 (CCPA 1980) Applicant further argues that amended claims recite the proportions of polyol from 30-40% and NADAU-FOURCADE teaches at para 0080-0081 that the polyol comprises 0.1-40% and preferably up to 90% glycerol polyol in the emulsion composition. Therefore, the argument of additional wetting agents as being required in lower amounts than claimed are unfounded since the water and oil emulsion requires greater amounts that overlap the amended claimed range and therefore make a prima facie case of obviousness the claims at hand. [W]hen a patent 'simply arranges old elements with each performing the same function it had been known to perform' and yields no more than one would expect from such an arrangement, the combination is obvious. [KSR Int'l Co. v.Teleflex Inc., 550 U.S. at 418 (quoting Sakraida v. Ag Pro, Inc., 425 U.S. 273,282 (1976).] Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to NECHOLUS OGDEN JR whose telephone number is (571)272-1322. The examiner can normally be reached 8-4:30 EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-1498. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NECHOLUS OGDEN JR/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Show 4 earlier events
Dec 18, 2025
Request for Continued Examination
Dec 23, 2025
Response after Non-Final Action
Feb 06, 2026
Non-Final Rejection mailed — §103
May 06, 2026
Response Filed
Jul 16, 2026
Final Rejection mailed — §103
Oct 15, 2026
Request for Continued Examination
Oct 16, 2026
Response after Non-Final Action
Oct 29, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12790564
NONIONIC FUNCTIONALIZED POLY ALKYL GLUCOSIDES AS ENHANCERS FOR FOOD SOIL REMOVAL
4y 10m to grant Granted Nov 10, 2026
Patent 12781158
PROCESS OF MAKING A WATER-SOLUBLE UNIT DOSE ARTICLE
3y 5m to grant Granted Nov 03, 2026
Patent 12778869
CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS
3y 4m to grant Granted Nov 03, 2026
Patent 12774433
Zero Waste Soap Container
3y 7m to grant Granted Oct 27, 2026
Patent 12758474
HYDRO-ALCOHOLIC COMPOSITION FOR HAND DISINFECTION
3y 9m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
70%
Grant Probability
93%
With Interview (+23.6%)
2y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1056 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month